Literature DB >> 17305551

Effects of psychiatric medications on sleep and sleep disorders.

Nicholas A DeMartinis1, Andrew Winokur.   

Abstract

Insomnia is a significant public health concern that has prompted substantial efforts to develop treatment and management strategies. A significant proportion of complaints of insomnia are related to psychiatric conditions such as anxiety disorders and depression, and treatments for these disorders are known to exert both direct and indirect benefits on sleep as well as some negative effects on sleep and sleep physiology. Insomnia is also a prominent symptom of a number of other psychiatric disorders, including schizophrenia and bipolar disorder. The observed impact of a variety of psychiatric medications on insomnia has prompted an empirically derived practice of treating non-psychiatric disorder-related insomnia with psychiatric medications by clinicians searching for alternatives to established medication treatments for primary insomnia. This article aims to review the evidence of the impact of psychiatric medications on sleep physiology, sleep disorders in psychiatric conditions, and on primary sleep disorders. The potential for exploiting the relevant pharmacological mechanisms of action in drug development for primary insomnia will be addressed as well.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17305551     DOI: 10.2174/187152707779940835

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  22 in total

1.  Doxepin in children and adolescents with symptoms of insomnia: a single-center experience.

Authors:  Yash D Shah; Virginia Stringel; Ivan Pavkovic; Sanjeev V Kothare
Journal:  J Clin Sleep Med       Date:  2020-02-07       Impact factor: 4.062

2.  Sleep Fragmentation Does Not Explain Misperception of Latency or Total Sleep Time.

Authors:  Austin Saline; Balaji Goparaju; Matt T Bianchi
Journal:  J Clin Sleep Med       Date:  2016-09-15       Impact factor: 4.062

3.  A preliminary study of sleep in adolescents with bipolar disorder, ADHD, and non-patient controls.

Authors:  Benjamin C Mullin; Allison G Harvey; Stephen P Hinshaw
Journal:  Bipolar Disord       Date:  2011-06       Impact factor: 6.744

4.  Decreased brain serotonin turnover rate following administration of Sharbat-e-Ahmed Shah produces antidepressant and anxiolytic effect in rats.

Authors:  Muhammad Ahmed; Aisha Azmat
Journal:  Metab Brain Dis       Date:  2017-07-07       Impact factor: 3.584

5.  Sleep functioning in relation to mood, function, and quality of life at entry to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Authors:  June Gruber; Allison G Harvey; Po W Wang; John O Brooks; Michael E Thase; Gary S Sachs; Terence A Ketter
Journal:  J Affect Disord       Date:  2008-08-15       Impact factor: 4.839

6.  Use of Selective Serotonin Reuptake Inhibitors and Sleep Quality: A Population-Based Study.

Authors:  Nikkie Aarts; Lisette A Zuurbier; Raymond Noordam; Albert Hofman; Henning Tiemeier; Bruno H Stricker; Loes E Visser
Journal:  J Clin Sleep Med       Date:  2016-07-15       Impact factor: 4.062

7.  [Insomnias. II. Pharmacological and psychotherapeutic treatment options].

Authors:  Dieter Riemann; Göran Hajak
Journal:  Nervenarzt       Date:  2009-11       Impact factor: 1.214

8.  Genetic variants in RBFOX3 are associated with sleep latency.

Authors:  Najaf Amin; Karla V Allebrandt; Ashley van der Spek; Bertram Müller-Myhsok; Karin Hek; Maris Teder-Laving; Caroline Hayward; Tõnu Esko; Josine G van Mill; Hamdi Mbarek; Nathaniel F Watson; Scott A Melville; Fabiola M Del Greco; Enda M Byrne; Edwin Oole; Ivana Kolcic; Ting-Hsu Chen; Daniel S Evans; Josef Coresh; Nicole Vogelzangs; Juha Karjalainen; Gonneke Willemsen; Sina A Gharib; Lina Zgaga; Evelin Mihailov; Katie L Stone; Harry Campbell; Rutger Ww Brouwer; Ayse Demirkan; Aaron Isaacs; Zoran Dogas; Kristin D Marciante; Susan Campbell; Fran Borovecki; Annemarie I Luik; Man Li; Jouke Jan Hottenga; Jennifer E Huffman; Mirjam Cgn van den Hout; Steven R Cummings; Yurii S Aulchenko; Philip R Gehrman; André G Uitterlinden; Heinz-Erich Wichmann; Martina Müller-Nurasyid; Rudolf Sn Fehrmann; Grant W Montgomery; Albert Hofman; Wen Hong Linda Kao; Ben A Oostra; Alan F Wright; Jacqueline M Vink; James F Wilson; Peter P Pramstaller; Andrew A Hicks; Ozren Polasek; Naresh M Punjabi; Susan Redline; Bruce M Psaty; Andrew C Heath; Martha Merrow; Gregory J Tranah; Daniel J Gottlieb; Dorret I Boomsma; Nicholas G Martin; Igor Rudan; Henning Tiemeier; Wilfred Fj van IJcken; Brenda W Penninx; Andres Metspalu; Thomas Meitinger; Lude Franke; Till Roenneberg; Cornelia M van Duijn
Journal:  Eur J Hum Genet       Date:  2016-05-04       Impact factor: 4.246

9.  Selective serotonin reuptake inhibitor use is associated with worse sleep-related breathing disturbances in individuals with depressive disorders and sleep complaints: a retrospective study.

Authors:  Rébecca Robillard; Mysa Saad; Laura B Ray; Brad BuJáki; Alan Douglass; Elliott K Lee; Louis Soucy; Naomi Spitale; Joseph De Koninck; Tetyana Kendzerska
Journal:  J Clin Sleep Med       Date:  2021-03-01       Impact factor: 4.062

10.  Sleep, fatigue, and functional health in psychotic patients.

Authors:  Flavie Waters; Neepa Naik; Daniel Rock
Journal:  Schizophr Res Treatment       Date:  2013-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.